LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/04/2026
Back to search
Official data from USPTO
DUOHEXABODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DUOHEXABODY
ST13
US500000079253337Class
1, 5, 42, 45
Filing
79253337
Registration
5993053
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/04/2026
Trademark type
Word
Nice classes
1, 5, 42, 45
Filing date
11/15/2018
Registration date
02/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Utrecht, NL
Examiner
CAPSHAW, DANIEL
Current location
Historical data usage
Holders and representatives
Holders
Genmab Holding B.V.
Genmab Holding B.V.
Representatives
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiologicalbiotechnological preparationsantibodiesbi- and multispecific antibodies as well as antibody fragmentsincluding monovalent antibodiesderivatives or conjugates of any of thesefor in vitro and in vivo scientific and industrial research and development with regard to diseases; Active chemical ingredients for use in the manufacture of pharmaceuticals
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations based on antibodiesbi- and multispecific antibodies as well as antibody fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these for use with regard to the treatment of cancerinfectiousimmuneautoimmuneinflammatoryneurodegenerative and cardiovascular diseases
Class 42
Medicalscientific and biological researchespecially research into antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these; chemical analysis; computer programmingprogramming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapyincluding scientific researchdevelopment and therapy with antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these
Class 45
Legal services in the field of patent exploitationpatent consultationpatent licensingproviding information about patent rights; licensing of intellectual property in the field of medicine
Publications
History of USPTO decisions and trademark events.
41 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/16/2026
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
06/16/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
03/05/2026
ES71
TEAS SECTION 71 RECEIVED
02/24/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/24/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/25/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/22/2020
FIMP
FINAL DISPOSITION PROCESSED
06/22/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/25/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
ALIE
ASSIGNED TO LIE
11/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2019
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
10/31/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/19/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/13/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/13/2019
CNSL
SUSPENSION LETTER WRITTEN
09/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2019
RFNT
REFUSAL PROCESSED BY IB
04/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/20/2019
RFRR
REFUSAL PROCESSED BY MPU
03/20/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/12/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/08/2019
CNRT
NON-FINAL ACTION WRITTEN
03/07/2019
DOCK
ASSIGNED TO EXAMINER
03/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/28/2019
Continuous trademark protection
Get notified about every new filing that threatens DUOHEXABODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.